Trial intelligence / Profile preview

Aloe vera fresh leaf versus silver sulfadiazine for second-degree burns in children

PACTR202208841557072Not yet recruiting

Sponsor
Edward Francis Small Teaching Hospital
Start
Dec 2022
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of aloe vera and silver sulfadiazine in partial-thickness burn (2 arms), sponsored by Edward Francis Small Teaching Hospital. Primary endpoint: Time to complete epithelialization. Planned start Dec 2022; status: not yet recruiting.

02

Drugs

aloe verasilver sulfadiazine
03

Conditions

partial-thickness burn

Beyond the preview

Go deeper on PACTR202208841557072.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202208841557072.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call